Evidence map›Paper›PMID 23392717›Full record

Trial reportJournal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban2013

Influence of intensive insulin therapy on vascular endothelial growth factor in patients with severe trauma.

Xiao-Dong Zhao, Yu-Hong Qin, Jun-Xun Ma, Wei Dang, Man Wang, Xian Zhang, Hong-Sheng Liu, Jian-Bo Zhang, Yong-Ming Yao, Lian-Yang Zhang and 1 more

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xiao-Dong ZhaoEmergency Department, the First Affiliated Hospital of PLA General Hospital, Beijing, 100048, China.
Yu-Hong QinEmergency Department, the First Affiliated Hospital of PLA General Hospital, Beijing, 100048, China.
Jun-Xun MaEmergency Department, the First Affiliated Hospital of PLA General Hospital, Beijing, 100048, China.
Wei DangEmergency Department, the First Affiliated Hospital of PLA General Hospital, Beijing, 100048, China.
Man WangEmergency Department, the First Affiliated Hospital of PLA General Hospital, Beijing, 100048, China.
Xian ZhangEmergency Department, the First Affiliated Hospital of PLA General Hospital, Beijing, 100048, China.
Hong-Sheng LiuEmergency Department, the First Affiliated Hospital of PLA General Hospital, Beijing, 100048, China.
Jian-Bo ZhangEmergency Department, the First Affiliated Hospital of PLA General Hospital, Beijing, 100048, China.
Yong-Ming YaoEmergency Department, the First Affiliated Hospital of PLA General Hospital, Beijing, 100048, China.
Lian-Yang ZhangInstitute of Field Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, 400042, China.
Qin SuEmergency Department, the First Affiliated Hospital of PLA General Hospital, Beijing, 100048, China. Suqin1117@yahoo.com.cn.
First Affiliated Hospital of Chinese PLA General Hospital · CNArmy Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The influence of early-stage intensive insulin therapy on the plasma levels of vascular endothelial growth factor (VEGF) and the related parameters in patients with severe trauma and the clinical implication were investigated. Sixty-four cases of severe trauma (injury severity score ≥20) with stress hyperglycemia (blood glucose >9 mmol/L) were randomly divided into intensive insulin therapy group and conventional therapy group. ELISA method, radioimmunoassay and density gradient gradation one-step process were used to determine plasma VEGF, endothelin-1 (ET-1), and the number of circulating endothelial cells (CECs) at the day of 0, 2, 3, 5 and 7 after admission. Simultaneously, the changes of CRP concentration in plasma were monitored to evaluate inflammatory response. The results showed that plasma levels of observational indexes in patients receiving early-stage intensive insulin therapy were all significantly lower than those in conventional therapy groups 2, 3, 5 and 7 days after admission [for VEGF (ng/L), 122.2±23.8 vs. 135.9±26.5, 109.6±27.3 vs. 129.0±18.4, 88.7±18.2 vs. 102.6±27.3, 54.2±26.4 vs. 85.7±35.2, P<0.05, 0.01, 0.05, 0.05 respectively; for ET-1 (ng/L), 162.8±23.5 vs. 173.7±13.2, 128.6±17.5 vs. 148.8±22.4, 96.5±14.8 vs. 125.7±14.8, 90.7±16.9 vs. 104.9±22.5, P<0.05, 0.01, 0.01, 0.01 respectively; for CRP (mg/L), 23.2±13.8 vs. 31.9±16.5, 13.6±17.3 vs. 23.5±18.4, 8.7±10.2 vs. 15.6±13.3, 5.2±9.4 vs. 10.7±11.2, all P<0.05; for CECs (/0.9 μL), 10.9±5.6 vs. 13.9±6.2, 8.5±4.9 vs. 11.3±5.3, 6.3±6.4 vs. 9.4±5.7, 4.8±7.1 vs. 7.8±4.8, all P<0.05]. It was concluded that intensive insulin therapy could antagonize the endothelium injury after trauma and reduce inflammation response quickly, which was one of important mechanisms by which intensive insulin therapy improves the prognosis of trauma patients.

Indexed as

AdultEndothelin-1FemaleHumansHyperglycemiaHypoglycemic AgentsInsulinMaleReproducibility of ResultsSensitivity and SpecificityTreatment OutcomeVascular Endothelial Growth Factor AWounds and InjuriesEndothelin-1Hypoglycemic AgentsInsulinVascular Endothelial Growth Factor A

Identifiers

PMID23392717
OpenAlexW2327897027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.